Bronchogen

FDA APPROVAL PENDING

Moderate Research

Immunity

Immunity

Bronchogen

Amino acid sequence

4

Amino acids

432da

Molecular weight

Peptide

Type

Bronchogen is a Khavinson bioregulator tetrapeptide (AEDL) with primary effects on the bronchopulmonary system. Developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson, it targets bronchial tissue and supports respiratory function. Like other Khavinson peptides, Bronchogen penetrates cell nuclei to influence gene expression related to respiratory tissue maintenance and repair.

Top researched benefits

Overview of Bronchogen

Bronchogen works through epigenetic regulation by penetrating cell and nuclear membranes to interact with DNA and modulate gene expression in bronchial tissue. It regulates protein synthesis in bronchopulmonary cells, supporting maintenance and repair of respiratory epithelium. The tetrapeptide structure allows efficient cellular uptake and tissue-specific targeting to bronchial structures.

Respiratory Support

  • Supports bronchial tissue through gene expression regulation.
  • Helps maintain respiratory epithelium health.
  • Regulates protein synthesis in lung tissue.

Antiaging

  • Addresses age-related changes in bronchial tissue.
  • Modulates gene expression in respiratory cells.

Storage

Oral capsules: room temperature. Injectable: 2-8°C refrigerated

Frequency

Daily for 10-20 days per cycle

Typical Dose

10-20 mg oral or 10 mg injectable

Cycle Duration

10-20 days

Chemical Makeup

Key benefits

Supports bronchial tissue function

Regulates protein synthesis in lungs

Targets bronchopulmonary system

Maintains respiratory epithelium

Part of Khavinson bioregulator family

Epigenetic mechanism of action

Tissue-specific targeting

Well-tolerated in research

Community interest

This peptide is still gaining traction in the community.

AEDL Tetrapeptide | Bronchial Bioregulator

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

Bronchogen Molecular Information

View the scientifc details of Bronchogen.

4

Amino Acids

Bronchogen

Ala

Ala

Position 1

Glu

Glu

Position 2

Asp

Asp

Position 3

Leu

Leu

Position 4

Amino acid sequence
AlaninePosition 1
Glutamic acidPosition 2
Aspartic acidPosition 3
LeucinePosition 4

Molecular Weight

432Da

Chain Length

4Amino Acids

Type

Peptide

Bronchogen Protocols

Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles.

GoalDosageFrequencyRoute
Standard protocol1010 week rangeOral capsules
Maintenance102 week rangeOral capsules

Bronchogen Cycle

The Bronchogen Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
Gene expression modulation begins
Week 0-0
Effects persist due to epigenetic changes
Week 0-0
Respiratory function improvements
Week 0-0
Cumulative benefits with periodic cycles

Dosing tools

Bronchogen Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

Bronchogen

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg Bronchogen vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
Bronchogen
Dosing
10-20 mg oral or 10 mg injectable
Dosing Frequency
Daily for 10-20 days per cycle
Cycle Duration
10-20 days
Storage
Oral capsules: room temperature. Injectable: 2-8°C refrigerated

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of Bronchogen interactions with other common peptides and substances.

Longevity

cho

Immunity

Chonluten

SYNERGISTIC

Related respiratory bioregulators; complementary mechanisms.

SYNERGISTIC

Longevity

cry

Immunity

Crystagen

COMPATIBLE

Both have immune-modulating properties; different tissue targets.

COMPATIBLE

Longevity

epi

Immunity

Epitalon

SYNERGISTIC

Often combined in comprehensive anti-aging Khavinson protocols.

SYNERGISTIC

Longevity

vil

Immunity

Vilon

COMPATIBLE

Part of Khavinson bioregulator family; targets different tissue.

COMPATIBLE

Side effects

Contraindications

Active respiratory emergencies (seek medical care)

Known hypersensitivity

Pregnancy or breastfeeding

Stop signs

Allergic reactions

Unusual respiratory symptoms

Bad signs

DiscolorationUnusual odorDamaged packaging
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

BronchogenResearch References

Bronchogen is a moderate research compound

3Research references

Bronchogen

Bronchogen is a moderate research compound

Khavinson Peptide Bioregulators

Comprehensive review of bioregulator peptides including respiratory bioregulators.

n.d.

Short Peptides and Bronchial Function

Tetrapeptides derived from bronchial tissue regulate protein synthesis in respiratory cells.

n.d.

Bioregulator Peptides and Respiratory Health

Short peptides support bronchopulmonary system through epigenetic mechanisms.

n.d.